Wednesday, March 17, 2021 11:35:11 AM
Shorting 790,505 shares of BRTX stock represents approximately a mere $9,000 in cash if the stock were to go to $0. It's virtually nothing in this scenario and cannot have any real effect whatsoever on the stock price moving forward.
The reality is that it actually means that the majority of the millions upon millions of shareholders are holding for the long run which is a very good thing!
Do not worry about dilution, it is not a factor with this stock, it is actually another good thing for reasons I have posted several times already. Those who go on about dilution are repeating pedestrian information which is not relevant to this company at this point.
I am not worrying about the announced reporting, there are no real deadlines that affect this company yet because of the recent emergence from bankruptcy.
The reporting will get done and when it is complete, the stock has nowhere to go but up..... a lot!
This is a highly anticipated issue and will explode in the near future.
Pro-Advisor
Recent BRTX News
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 12/05/2024 10:37:59 PM
- BioRestorative Therapies Announces Notice of Allowance of Key New Patent Protecting ThermoStem® Metabolic Disease Program • GlobeNewswire Inc. • 12/05/2024 11:45:00 AM
- BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data • GlobeNewswire Inc. • 11/13/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 09:15:39 PM
- BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/12/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2024 09:43:22 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/06/2024 09:37:48 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 11/06/2024 09:25:26 PM
- BioRestorative Therapies to Present New Clinical Data at the ORS PSRS 7th International Spine Research Symposium • GlobeNewswire Inc. • 11/06/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/05/2024 09:33:45 PM
- BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health • GlobeNewswire Inc. • 11/05/2024 12:10:00 PM
- BioRestorative Therapies Receives Patent Allowance for ThermoStem® Metabolic Disease Program • GlobeNewswire Inc. • 10/31/2024 11:00:00 AM
- BioRestorative Therapies to Participate in Upcoming UBS and Maxim Group Investor Events • GlobeNewswire Inc. • 10/10/2024 11:00:00 AM
- BioRestorative Therapies to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference • GlobeNewswire Inc. • 10/03/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 08:33:16 PM
- BioRestorative Therapies’ IFATS 2024 Presentation to Feature ThermoStem® Platform’s Potential to Deliver a Superior Efficacy and Tolerability Profile Over GLP-1 Drugs • GlobeNewswire Inc. • 09/19/2024 10:55:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:30:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 08:11:03 PM
- BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/13/2024 08:05:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/08/2024 08:23:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:47:26 PM
- BioRestorative Therapies to Report Second Quarter 2024 Financial Results and Host Conference Call on August 13, 2024 • GlobeNewswire Inc. • 08/06/2024 08:05:00 PM
- BioRestorative Therapies’ Chief Scientist Named New Section Editor of the Prestigious Journal of Translational Medicine • GlobeNewswire Inc. • 07/23/2024 11:10:00 AM
- BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program • GlobeNewswire Inc. • 06/27/2024 11:40:00 AM
Basanite, Inc. to Open New Production and Distribution Facility in Northeast Ohio • BASA • Jan 2, 2025 8:28 AM
The Crypto Company Highlights Blockchain Training Alliance's Successes and Momentum for 2025 • CRCW • Dec 26, 2024 8:58 AM
Hertz Energy Provides Antimony and Critical Minerals Projects Update and Announces Financing • HZLIF • Dec 20, 2024 9:00 AM
North Bay Resources Announces Arrival of 42 Tons Gold Ore at Bishop Gold Mill, California • NBRI • Dec 20, 2024 9:00 AM
Consumer Automotive Finance Subsidiary Drago Knives Narrows Down Potential Partner to Manufacture Patented Throwing Knives • CAFI • Dec 20, 2024 9:00 AM
$ASNS - Is this the Next Big Cybersecurity Stock? How Actelis Networks is Revolutionizing Critical Infrastructure Protection • ASNS • Dec 20, 2024 8:50 AM